AI-based CT quantification reveals small airway loss and vascular simplification in rheumatoid arthritis-associated lung disease
摘要
To investigate pulmonary structural changes in patients with rheumatoid arthritis (RA) using an artificial intelligence (AI)-based CT segmentation model and evaluate the diagnostic potential of quantitative imaging biomarkers.
MethodsThis cross-sectional study included 556 non-smoking RA patients and 472 non-smoking healthy controls. An AI-based CT segmentation model was used to quantify total lung volume (TLV), percentage of low attenuation area (LAA%-200–700), total airway volume (TAV), small airway volume (TAV2mm), total vessel volume (TVV), small vessel volume (TVV5mm), vessel tortuosity (VT), and fractal dimension (FD). Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis. Subgroup analysis compared RA patients with and without respiratory symptoms.
ResultsRA patients exhibited significantly lower TLV, increased LAA%-200–700, marked reductions in small airway volume (TAV2mm) and small vessel volume (TVV5mm), and a minimal, albeit statistically significant, alteration in VT compared to healthy controls (all p < 0.001). TAV2mm demonstrated the highest single-parameter diagnostic performance (AUC: 0.801). The combination of TAV2mm, TVV5mm, and LAA%-200–700 achieved superior discrimination (AUC: 0.837). Symptomatic RA patients showed greater reductions in vascular volumes and more extensive interstitial abnormalities than asymptomatic patients (p < 0.05), confirming clinical relevance.
ConclusionRA patients exhibit quantifiable small airway loss and imaging features suggestive of vascular simplification. A combination of small airway, small vessel, and interstitial metrics effectively distinguishes RA patients from healthy controls.